Study Does Not Find Link Between Ovarian Cancer and Genital Powder Use
The largest study to date did not find a significant link overall between using powder in the genital area and ovarian cancer in women. However, because of the rarity of ovarian cancer, the study still may not have been large enough to detect a possible small increase in risk, according to the study authors.
FDA Approves Tazverik (Tazemetostat) for Epithelioid Sarcoma
The US Food and Drug Administration (FDA) has approved Tazverik (tazemetostat) to treat adults and children 16 and older with epithelioid sarcoma, a rare cancer which accounts for less than 1% of all soft tissue sarcomas.
Study Finds Antioxidants Risky During Breast Cancer Chemotherapy
Taking certain supplements while undergoing chemotherapy for breast cancer may do more harm than good. A small study found that patients who took antioxidants had higher chances of cancer recurrence and death.
Surgeon General Reports on Smoking Cessation for First Time in 30 Years
Surgeon General Vice Admiral Jerome M. Adams issued the first Surgeon General’s report on smoking cessation in 30 years. It reviews and updates the latest research on Americans’ attempts to quit smoking, what works, and why it’s so important.
FDA Approves Ayvakit (Avapritinib) for GIST
The US Food and Drug Administration (FDA) has approved Ayvakit (avapritinib) to treat people with advanced cases of gastrointestinal stromal tumor (GIST) that have a certain genetic mutation.